SuperworthTheriva Biologics market cap TOVX
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $9M
- Highest close in our data
- $290M
- Sep 2015
Theriva Biologics is worth $9M at the close on Oct 23, 2026, at $0.20 a share.
That is up 172% over the last year and down 84% over five years.
Its highest close in our data was $290M in Sep 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9M | $6.1M | $17.9M | +39% |
| 2025 | $6.5M | $1.5M | $9.2M | +58% |
| 2024 | $4.1M | $1.5M | $9M | −44% |
| 2023 | $7.3M | $7M | $17M | +2% |
| 2022 | $7.2M | $6.7M | $68.1M | −80% |
| 2021 | $35.9M | $12.1M | $119.1M | +369% |
| 2020 | $7.7M | $5M | $11.9M | −13% |
| 2019 | $8.8M | $6.6M | $11M | +13% |
| 2018 | $7.8M | $3.1M | $69.3M | −88% |
| 2017 | $65.2M | $57.8M | $125.8M | −7% |
| 2016 | $70.2M | $70.2M | $247.7M | −66% |
| 2015 | $207.7M | $110.8M | $290M | +94% |
| 2014 | $107.2M | $74.5M | $165.3M | +55% |
| 2013 | $69.1M | $45.5M | $87.3M | −3% |
| 2012 | $71.2M | $46.2M | $89.5M | +100% |
| 2011 | $35.5M | $14M | $40M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Theriva Biologics' size, closest first, today.
| Company | Market cap |
|---|---|
| TOVXTheriva Biologics | $9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Theriva Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.